|Day Low/High||402.82 / 408.10|
|52 Wk Low/High||281.89 / 433.74|
In this day and age, companies must be 'disruptors' or get left in the dust.
Top Award of $250,000 Goes to Ana Humphrey of Virginia in Nation's Oldest and Most Prestigious STEM Competition for High School Seniors
Only therapy that targets the IL-4/IL-13 pathway, a key driver of the allergic or type 2 inflammation that underlies atopic dermatitis
* Only therapy that targets the IL-4/IL-13 pathway, a key driver of the allergic or type 2 inflammation that underlies atopic dermatitis
Teva's CEO explains why 2019 is a trough year for the Israeli pharma company.
* This is the latest step by the companies to help make Praluent more accessible and affordable for appropriate patients
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: JKS, KCAP, LAUR, REGN, WAT Downgrades: CVRR, IIIN Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
So far 2019 is proving to be a year where things have a habit of working out right.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.